Narayana Hrudayalaya Resultados de beneficios anteriores

Pasado controles de criterios 6/6

Narayana Hrudayalaya ha aumentado sus beneficios a una tasa media anual de 53%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 29.7% anual. Los ingresos han ido creciendo a una tasa media de 12.8% al año. La rentabilidad financiera de Narayana Hrudayalaya es de 30.8%, y sus márgenes netos son de 15.5%.

Información clave

53.0%

Tasa de crecimiento de los beneficios

53.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	29.4%
Tasa de crecimiento de los ingresos	12.8%
Rentabilidad financiera	30.8%
Margen neto	15.5%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Apr 09

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Mar 20

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Mar 04

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Dec 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Dec 05

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Nov 08

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Oct 21

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Aug 01

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Jul 07

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Jun 22

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Jan 19

We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation

Aug 20

Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher

Aug 07

Is Narayana Hrudayalaya (NSE:NH) Using Too Much Debt?

Dec 10

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Narayana Hrudayalaya. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NSEI:NH Ingresos, gastos y beneficios (INR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	49,688	7,717	1,773
30 Sep 23	48,933	7,375	1,773
30 Jun 23	47,297	6,796	1,773
31 Mar 23	45,297	6,062	1,773
31 Dec 22	42,439	5,020	1,387
30 Sep 22	40,755	4,457	1,387
30 Jun 22	38,746	3,763	1,387
31 Mar 22	37,013	3,419	1,387
31 Dec 21	36,047	3,410	1,123
30 Sep 21	33,954	2,843	1,123
30 Jun 21	30,559	1,816	1,123
31 Mar 21	25,839	-143	1,123
31 Dec 20	25,049	-704	1,497
30 Sep 20	25,397	-798	1,497
30 Jun 20	27,677	-310	0
31 Mar 20	31,365	1,189	1,497
31 Dec 19	31,705	1,441	1,781
30 Sep 19	31,152	1,254	1,781
30 Jun 19	30,009	936	1,781
31 Mar 19	28,740	592	1,837
31 Dec 18	27,507	318	1,529
30 Sep 18	25,728	332	1,529
30 Jun 18	24,233	362	1,529
31 Mar 18	22,943	513	1,529
31 Dec 17	21,243	639	1,234
30 Sep 17	20,259	668	1,234
30 Jun 17	19,494	767	0
31 Mar 17	18,884	831	1,234
31 Dec 16	18,220	637	839
30 Sep 16	17,553	525	839
30 Jun 16	16,868	364	839
31 Mar 16	16,176	212	1,094
31 Dec 15	15,471	219	1,239
31 Mar 15	13,683	-168	848
31 Mar 14	10,983	317	1,050

Ingresos de calidad: NH tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (15.5%) de NH son superiores a los del año pasado (11.8%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lNH han crecido significativamente en un 53% al año.

Acelerando crecimiento: El crecimiento de los beneficios de NH en el último año (53.7%) supera su media de 5 años (53% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de NH en el último año (53.7%) superó al de la industria Healthcare 29.5%.

Rentabilidad financiera

Alta ROE: La rentabilidad financiera (30.8%) de NH se considera alta.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Narayana Hrudayalaya Resultados de beneficios anteriores

Pasado controles de criterios 6/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Recent updates

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 16%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Price target increased by 8.2% to ₹1,070

Consensus EPS estimates increase by 11%

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Upcoming dividend of ₹2.50 per share at 0.3% yield

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya (NSE:NH) Seems To Use Debt Rather Sparingly

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Is Well Worth Watching

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Full year 2022 earnings: EPS misses analyst expectations

Narayana Hrudayalaya Limited Recommends Dividend for the Year Ended March 31, 2022

Price target increased to ₹729

Insufficient new directors

Insufficient new directors

Narayana Hrudayalaya Limited Announces Appointment of Viren Prasad Shetty as Executive Vice-Chairman

Returns On Capital Are A Standout For Narayana Hrudayalaya (NSE:NH)

Insufficient new directors

Price target increased to ₹707

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Is Narayana Hrudayalaya (NSE:NH) A Risky Investment?

A Look At The Intrinsic Value Of Narayana Hrudayalaya Limited (NSE:NH)

Second quarter 2022 earnings released: EPS ₹4.89 (vs ₹0.17 loss in 2Q 2021)

We Think Narayana Hrudayalaya (NSE:NH) Can Manage Its Debt With Ease

We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation

Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher

First quarter 2022 earnings released: EPS ₹3.75 (vs ₹5.90 loss in 1Q 2021)

Additional Non-Executive & Independent Director Nivruti Rai has left the company

Full year 2021 earnings released: ₹0.70 loss per share (vs ₹5.86 profit in FY 2020)

Price target increased to ₹525

Narayana Hrudayalaya Limited to Report Q3, 2021 Results on Feb 05, 2021

Desglose de ingresos y gastos
Beta